The news story you are looking for has expired. A more recent related article is displayed below.

Sponsored Links

Angel Biotechnology Holdings plc signs GMP contract with ReNeuron for Phase I clinical trial

Jun 09, 2009 (M2 EQUITYBITES via COMTEX) --

Company: ReNeuron Group PLC (RNUGF)

Angel Biotechnology Holdings plc (AIM: ABH), a biopharmaceutical contract manufacturer, said today (9 June) that it has entered into a GMP manufacturing contract with UK-based stem cell business ReNeuron Group plc.

This follows ReNeuron's recent MHRA regulatory approval to begin a clinical trial with stem cell therapy for stroke.

Angel will be ReNeuron's manufacturing partner and will produce its ReN001 stem cell product for a Phase I clinical trial.

The value of the contract was not disclosed. 

Comments on this story may be sent to admin@m2.com

Copyright (C) 2009 M2. All rights reserved

News Provided by COMTEX

Company: ReNeuron Group PLC (RNUGF)


Related terms: biotechnology, business, clinical, contract, health, manufacturer, manufacturing, trial

Related Articles

ReNeuron signs manufacturing contract with Angel Biotechnology - Zibb.com
Jun 9, 2009
...contract with Angel Biotechnology British stem cell company ReNeuron...with UK-based Angel Biotechnology Holdings, under which...grade ReN001 stem cell lots for ReNeuron's Phase I clinical trial with its ReN001...

Call for tolerance towards some 'stem cell tourism'
Jul 5, 2009
Call for tolerance towards some 'stem cell tourism' 05 July 2009 Magazine issue...internet may be awash with bogus or untested stem cell-based treatments targeted at unwary...guidelines designed to crack down on "stem cell tourism". The team insist their new...

ReNeuron Signs Manufacturing Contract with Angel Biotechnology Ltd To Provide Stem Cells For Stroke Clinical Trial
Jun 9, 2009
...Contract with Angel Biotechnology Ltd To Provide...For Stroke Clinical Trial 6/9...contract with Angel Biotechnology Holdings plc (“Angel...grade ReN001 stem cell lots for ReNeuron...s Phase I clinical trial with its ReN001...

Pluristem Therapeutics Inc granted European regulatory approval for placental-derived stem cell
Jun 16, 2009
...approval for placental-derived stem cell clinical trial Pluristem Therapeutics Inc...approval of the company's Clinical Trial Application (CTA). The...world's "first-in-man" clinical trial using PLX-PAD, Pluristem...